Challenges in Performing Real-World Evidence Studies in Low-Middle Income Countries: the EdoBRA Study.
作者信息
Massaro Ayrton Roberto
机构信息
Hospital Sírio-libanês - Neurologia, São Paulo, SP - Brasil.
出版信息
Arq Bras Cardiol. 2025 Jul 28;122(4):e20250353. doi: 10.36660/abc.20250353. eCollection 2025.
Abstract
摘要
相似文献
1
Challenges in Performing Real-World Evidence Studies in Low-Middle Income Countries: the EdoBRA Study.
Arq Bras Cardiol. 2025 Jul 28;122(4):e20250353. doi: 10.36660/abc.20250353. eCollection 2025.
2
Interventions for improving coverage of childhood immunisation in low- and middle-income countries.
Cochrane Database Syst Rev. 2023 Dec 6;12(12):CD008145. doi: 10.1002/14651858.CD008145.pub4.
3
Measurement of social capital in relation to health in low and middle income countries (LMIC): a systematic review.
Soc Sci Med. 2015 Mar;128:95-104. doi: 10.1016/j.socscimed.2015.01.005. Epub 2015 Jan 8.
4
Post-Asphyxial Aftercare and Management of Neonates in Low- and Middle-Income Countries: A Systematic Evidence Synthesis.
Neonatology. 2025;122(Suppl 1):84-105. doi: 10.1159/000541862. Epub 2024 Nov 13.
5
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries.
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD010398. doi: 10.1002/14651858.CD010398.
6
Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.
Ther Adv Vaccines Immunother. 2025 Jul 24;13:25151355251356646. doi: 10.1177/25151355251356646. eCollection 2025.
7
Digital interventions for common mental health problems among older adults in low- and middle-income countries: a scoping review.
BMJ Glob Health. 2025 Jun 24;10(6):e017836. doi: 10.1136/bmjgh-2024-017836.
8
End-stage paediatric heart failure in low- and middle-income countries: challenges in surgical management.
Indian J Thorac Cardiovasc Surg. 2025 Jun;41(6):768-783. doi: 10.1007/s12055-024-01853-z. Epub 2024 Nov 25.
9
Centre-based day care for children younger than five years of age in low- and middle-income countries.
Cochrane Database Syst Rev. 2014 Sep 25;2014(9):CD010543. doi: 10.1002/14651858.CD010543.pub2.
10
A systematic review of public health interventions to address breast cancer inequalities in low- and middle-income countries.
Syst Rev. 2024 Jul 25;13(1):195. doi: 10.1186/s13643-024-02620-2.
本文引用的文献
1
Effectiveness and Safety of Edoxaban in the Routine Clinical Care of Atrial Fibrillation Patients in Brazil: Prospective 1-Year Follow-Up Study - EdoBRA.
Arq Bras Cardiol. 2025 Apr 14;122(4):e20240589. doi: 10.36660/abc.20240589. eCollection 2025.
2
Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association.
Europace. 2025 Mar 5;27(3). doi: 10.1093/europace/euaf019.
3
Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF Program.
Clin Cardiol. 2025 Feb;48(3):e70091. doi: 10.1002/clc.70091.
4
Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke.
Neurology. 2025 Mar 25;104(6):e213426. doi: 10.1212/WNL.0000000000213426. Epub 2025 Feb 25.
5
Characteristics Associated with Prevalent Atrial Fibrillation and Risk Profile for Incident Atrial Fibrillation an Elderly Population from ELSA-Brasil.
Arq Bras Cardiol. 2025 Jan;122(1):e20240487. doi: 10.36660/abc.20240487.
6
The impact of competing stroke etiologies in patients with atrial fibrillation.
Eur Stroke J. 2023 Sep;8(3):703-711. doi: 10.1177/23969873231185220. Epub 2023 Jul 4.
7
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
J Am Coll Cardiol. 2018 Sep 25;72(13):1466-1475. doi: 10.1016/j.jacc.2018.07.037.
8
Edoxaban versus warfarin in patients with atrial fibrillation.
N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.
9
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.
Ann Intern Med. 2007 Jun 19;146(12):857-67. doi: 10.7326/0003-4819-146-12-200706190-00007.
10
Misuse of antithrombotic therapy in atrial fibrillation patients: frequent, pervasive and persistent.
J Thromb Thrombolysis. 2007 Feb;23(1):65-71. doi: 10.1007/s11239-006-9012-9.
Zotero 插件